My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 134

    1.

    Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study.

    Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Bonadonna RC, Muggeo M; Bruneck study.

    Diabetes Care. 2003 Apr;26(4):1251-7.PMID: 12663606 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Metabolic syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study.

    Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Bonadonna RC, Muggeo M; Bruneck Study.

    Int J Obes Relat Metab Disord. 2003 Oct;27(10):1283-9.PMID: 14513078 [PubMed - indexed for MEDLINE]Related articles

    3.

    The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.

    Tong PC, Kong AP, So WY, Yang X, Ho CS, Ma RC, Ozaki R, Chow CC, Lam CW, Chan JC, Cockram CS.

    Diabetes Care. 2007 May;30(5):1206-11. Epub 2007 Jan 26.PMID: 17259472 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes.

    Lorenzo C, Williams K, Hunt KJ, Haffner SM.

    Diabetes Care. 2007 Jan;30(1):8-13.PMID: 17192325 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Plasma glucose within the normal range is not associated with carotid atherosclerosis: prospective results in subjects with normal glucose tolerance from the Bruneck Study.

    Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Bonadonna R, Muggeo M.

    Diabetes Care. 1999 Aug;22(8):1339-46.PMID: 10480780 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies.

    Meigs JB, Wilson PW, Nathan DM, D'Agostino RB Sr, Williams K, Haffner SM.

    Diabetes. 2003 Aug;52(8):2160-7.PMID: 12882936 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study.

    McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, Ballantyne CM, Heiss G.

    Diabetes Care. 2005 Feb;28(2):385-90.PMID: 15677797 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: the Cardiovascular Health Study.

    Scuteri A, Najjar SS, Morrell CH, Lakatta EG; Cardiovascular Health Study.

    Diabetes Care. 2005 Apr;28(4):882-7.PMID: 15793190 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis.

    Reilly MP, Wolfe ML, Rhodes T, Girman C, Mehta N, Rader DJ.

    Circulation. 2004 Aug 17;110(7):803-9. Epub 2004 Aug 2.PMID: 15289378 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.

    de Simone G, Devereux RB, Chinali M, Best LG, Lee ET, Galloway JM, Resnick HE; Strong Heart Study Investigators.

    Diabetes Care. 2007 Jul;30(7):1851-6. Epub 2007 Apr 17.PMID: 17440172 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study.

    Bonora E, Targher G, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, Saggiani F, Poli M, Perbellini S, Raffaelli A, Gemma L, Santi L, Bonadonna RC, Muggeo M.

    Diabet Med. 2004 Jan;21(1):52-8.PMID: 14706054 [PubMed - indexed for MEDLINE]Related articles

    12.

    Metabolic syndrome and incident end-stage peripheral vascular disease: a 14-year follow-up study in elderly Finns.

    Wang J, Ruotsalainen S, Moilanen L, Lepistö P, Laakso M, Kuusisto J.

    Diabetes Care. 2007 Dec;30(12):3099-104. Epub 2007 Sep 11.PMID: 17848614 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Prevalence of coronary heart disease and carotid arterial thickening in patients with the metabolic syndrome (The ARIC Study).

    McNeill AM, Rosamond WD, Girman CJ, Heiss G, Golden SH, Duncan BB, East HE, Ballantyne C.

    Am J Cardiol. 2004 Nov 15;94(10):1249-54.PMID: 15541239 [PubMed - indexed for MEDLINE]Related articles

    14.

    The metabolic syndrome and nonfatal ischemic heart disease; a population-based study.

    Nabipour I, Amiri M, Imami SR, Jahfari SM, Shafeiae E, Nosrati A, Iranpour D, Soltanian AR.

    Int J Cardiol. 2007 May 16;118(1):48-53. Epub 2006 Jul 26.PMID: 16875744 [PubMed - indexed for MEDLINE]Related articles

    15.

    Metabolic syndrome and coronary heart disease in South Asians, African-Caribbeans and white Europeans: a UK population-based cross-sectional study.

    Tillin T, Forouhi N, Johnston DG, McKeigue PM, Chaturvedi N, Godsland IF.

    Diabetologia. 2005 Apr;48(4):649-56. Epub 2005 Mar 10.PMID: 15759110 [PubMed - indexed for MEDLINE]Related articles

    16.

    Metabolic syndrome and coronary heart disease equivalent conditions in predicting cardiovascular events in young to middle-aged adults.

    Akosah KO, McHugh VL, Mathiason MA, Kulkarni A, Barnhart SI.

    J Cardiometab Syndr. 2006 Summer;1(3):173-7.PMID: 17679809 [PubMed - indexed for MEDLINE]Related articles

    17.

    Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome.

    Bianchi C, Penno G, Malloggi L, Barontini R, Corfini M, Giovannitti MG, Di Cianni G, Del Prato S, Miccoli R.

    Nutr Metab Cardiovasc Dis. 2008 Jan;18(1):31-8. Epub 2007 Apr 8.PMID: 17420118 [PubMed - indexed for MEDLINE]Related articles

    18.

    Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis.

    Chung CP, Oeser A, Solus JF, Avalos I, Gebretsadik T, Shintani A, Raggi P, Sokka T, Pincus T, Stein CM.

    Atherosclerosis. 2008 Feb;196(2):756-63. Epub 2007 Jan 30.PMID: 17266963 [PubMed - indexed for MEDLINE]Related articles

    19.

    Markers of inflammation and prevalence of vascular disease in patients with metabolic syndrome.

    Novo G, Corrado E, Muratori I, Tantillo R, Bellia A, Galluzzo A, Vitale G, Novo S.

    Int Angiol. 2007 Dec;26(4):312-7.PMID: 18091698 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.

    Samaras K, Wand H, Law M, Emery S, Cooper D, Carr A.

    Diabetes Care. 2007 Jan;30(1):113-9. Erratum in: Diabetes Care. 2007 Feb;30(2):455. PMID: 17192343 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity